A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief
Published
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | article |
| Published: |
2009
|
| Online Access: | http://hdl.handle.net/10725/8038 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www-clinicalkey-com.ezproxy.lau.edu.lb:2443/service/content/pdf/watermarked/1-s2.0-S0022534709619686.pdf?locale=en_US |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!